Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2023/0494-GLECAPREVIR+PIBRENTASVIR [100 MG+40 MG;TRATAMENTO 8-16 SEMANAS]

Unlock Full Tender Insight

Complete details, deadlines, and AI-powered analysis are available inside the tend.ee platform. Create your free account to access.

It's free to get started. No credit card required.